Edinburgh start-up’s bionic hand promises ‘life-changing’ benefits for amputees
An Edinburgh start-up has secured significant six-figure funding to forward the development of its mechanical bionic hand.
Metacarpal will use the £800,000 in seed funding to accelerate its prosthetics development and improve the lives of amputees. Investors in the funding round included SIS Ventures, Scottish Enterprise, Worth Capital, Oxford Technology, the University of Strathclyde and Gabriel Investment Syndicate.
Advertisement
Hide AdAdvertisement
Hide AdBased in the Scottish capital, Metacarpal has used advanced engineering techniques to create a highly functional prosthetic hand that is completely controlled and powered by body motion, without the need for electronics. The bionic hand is said to combine the practicality of body-powered control with the functionality of a myoelectric prosthetic - including five-finger motion, variable grips and wrist positions.


The venture was founded by University of Strathclyde product design engineering graduate Fergal Mackie in 2020 and was inspired by an accident he had in the final year of his studies. After falling over and breaking both of his wrists, Fergal had to discover new ways to complete his daily tasks, sparking an interest in prosthetics.
To date, the majority of development in prosthetics has focused on robotic hands, leaving a gap in the market for body-powered devices. By providing a better alternative, the venture aims to enhance the acceptance rate of prosthetics.
The NHS estimates that more than a quarter of upper-limb amputees choose to wear no prosthetic at all rather than using any currently available products, while the global market for upper limb prosthetics is forecast to reach almost £1 billion by 2028.
Advertisement
Hide AdAdvertisement
Hide AdMackie, founder and chief executive, said: “Metacarpal was established to create a better quality of life for amputees. With the use of truly revolutionary, unique and disruptive technology, our body-powered bionic hand is raising the standard of upper-limb prosthetics. It is the only device to utilise reactive body-power technology giving fingers individual motion.
“The success of the seed funding round is a huge milestone for the business, which will enable us to develop our bionic into a commercially viable product with the potential to change the lives of prosthetics users. I cannot wait to see the impact that it has.”
The funding boost will enable Metacarpal to finalise the product, begin manufacturing units and double its headcount to eight.
Comments
Want to join the conversation? Please or to comment on this article.